Cumberland Partners Ltd bought a new stake in shares of Nutrien Ltd. (NYSE:NTR – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The firm bought 78,050 shares of the company’s stock, valued at approximately $4,582,000.
A number of other hedge funds and other institutional investors have also modified their holdings of NTR. Metis Global Partners LLC boosted its holdings in shares of Nutrien by 37.8% during the third quarter. Metis Global Partners LLC now owns 220,648 shares of the company’s stock worth $12,958,000 after purchasing an additional 60,491 shares during the period. Campbell & CO Investment Adviser LLC increased its stake in Nutrien by 122.1% in the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 68,124 shares of the company’s stock valued at $4,000,000 after buying an additional 37,447 shares during the period. Colrain Capital LLC lifted its position in Nutrien by 35.6% in the 3rd quarter. Colrain Capital LLC now owns 128,150 shares of the company’s stock worth $7,595,000 after buying an additional 33,650 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Nutrien by 20.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 69,551 shares of the company’s stock valued at $4,051,000 after buying an additional 11,704 shares during the period. Finally, Sagard Holdings Management Inc. acquired a new stake in shares of Nutrien during the 2nd quarter valued at $1,511,000. Institutional investors and hedge funds own 63.10% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on the stock. Wall Street Zen raised shares of Nutrien from a “hold” rating to a “buy” rating in a research note on Saturday, January 31st. Wells Fargo & Company initiated coverage on Nutrien in a research report on Tuesday, November 11th. They issued an “equal weight” rating and a $64.00 target price on the stock. Zacks Research raised Nutrien from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 27th. Morgan Stanley raised Nutrien from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $70.00 to $77.00 in a research note on Wednesday, January 14th. Finally, Oppenheimer restated an “outperform” rating on shares of Nutrien in a report on Tuesday, January 27th. Two investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $66.69.
Nutrien Stock Performance
Shares of NYSE NTR opened at $70.37 on Thursday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.89 and a current ratio of 1.41. The firm has a market cap of $33.88 billion, a price-to-earnings ratio of 18.97 and a beta of 0.73. The business’s 50-day simple moving average is $65.84 and its 200-day simple moving average is $60.49. Nutrien Ltd. has a 52 week low of $45.78 and a 52 week high of $73.55.
Nutrien (NYSE:NTR – Get Free Report) last posted its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.04). Nutrien had a return on equity of 7.54% and a net margin of 6.79%.The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.26 billion. During the same quarter last year, the firm posted $0.31 earnings per share. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. As a group, equities research analysts expect that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.
Nutrien News Summary
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Board boosts shareholder returns — Nutrien raised its quarterly dividend to US$0.55 and announced intent to repurchase up to 5% of outstanding shares, which can support the share price by returning capital and reducing float. Read More.
- Positive Sentiment: Management highlights strong operational performance and cost/capex discipline — the company said 2025 delivered exceptional performance across segments and lower costs/capex than targeted, and provided 2026 guidance (details in the release), which supports confidence in earnings quality. Read More.
- Neutral Sentiment: Analyst moves are mixed — Barclays raised its price target to $70 with an “equal weight” call, leaving the stock essentially in-line with current levels; other firms show a range of targets. Analyst tone is not uniformly bullish. Read More.
- Neutral Sentiment: Brokerage coverage: UBS reiterated a hold, reflecting cautious views from some sell-side firms despite buyback/dividend news. Read More.
- Negative Sentiment: Q4 results missed consensus — Nutrien reported adjusted EPS of $0.83 vs. the $0.87 consensus and revenue of $5.12B vs. ~$5.26B expected; the EPS/revenue miss is the primary negative driver putting near-term pressure on the stock. Read More.
- Negative Sentiment: Market reaction and mixed underlying metrics — some data providers and headlines note declines in certain quarterly metrics (revenue/gross profit down y/y in parts of the report) and the immediate market response was negative. That created selling pressure despite net-income and margin items that improved. Read More.
About Nutrien
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Recommended Stories
- Five stocks we like better than Nutrien
- Your Bank Account Is No Longer Safe
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR – Free Report).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
